Technical Challenges in Current Primo Vascular System Research and Potential Solutions  by Kang, Kyung A. et al.
Available online at www.sciencedirect.com
Journal of Acupuncture and Meridian Studies
journal homepage: www. jams-kpi .com
J Acupunct Meridian Stud 2016;9(6):297e306c
m
p
h
CREV IEW ART ICLETechnical Challenges in Current Primo
Vascular System Research and Potential
Solutions
Kyung A. Kang 1,*, Claudio Maldonado 2, Vitaly Vodyanoy 3,41 Department of Chemical Engineering, University of Louisville, Louisville, KY, USA
2 Department of Physiology and Biophysics, University of Louisville, Louisville, KY, USA
3 Department Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, and
School of Kinesiology, Auburn University, Auburn, AL, USA
4 The Research Department, The Edward Via College of Osteopathic Medicine, Auburn, AL, USA
Available online 17 February 2016Received: Sep 19, 2015
Revised: Jan 28, 2016
Accepted: Feb 8, 2016
KEYWORDS
Bonghan system;
primo vascular system;
PVS identification;
PVS harvest;
optical characterizationT
rea
ed
* C
E
ISSN
ttp
opyhis is an Open Access article dis
tivecommons.org/licenses/by-nc/
ium, provided the original work is
orresponding author. Department
-mail: Kyung.Kang@louisville.edu
2005-2901 eISSN 2093-8152
://dx.doi.org/10.1016/j.jams.201
right ª 2016, Medical AssociationAbstract
Since Bonghan Kim’s discovery of the Bonghan system (BHS) in the 1960s, numerous re-
ports have suggested that the system is fundamental for maintaining mammalian life.
The BHS is a circulatory system independent of the blood or the lymphatic system, forms
an extensive network throughout the entire mammalian body, has been reported to be
the acupuncture meridian, stores distinct types of stem cells, and appears to have some
roles in cancer metastasis. Despite Kim’s first report having been published as early as
1962, research progress has been rather slow mainly because the system is very small
and translucent, making it optically difficult to distinguish it from the hemoglobin-rich
surrounding tissues. Unfortunately, Kim did not describe in detail the methods that he
used for identifying and harvesting the system and the components of the system. In
2000, Kwang-Sup Soh reopened the BHS research, and since then, new and important sci-
entific findings on the system have been reported, and many of Kim’s results have been
verified. In 2010, the BHS was renamed the primo vascular system. Nevertheless, good
tools to properly deal with this system are still lacking. In this article, we address some
of the technical difficulties involved in studying the primo vascular system and attempt to
discuss potential ways to overcome those difficulties.tributed under the terms of the Creative Commons Attribution Non-Commercial License (http://
4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any
properly cited.
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In 1962, Bonghan Kim [1], a scientist in North Korea, re-
ported a discovery of a new vascular system in mammals,
which was soon named as the Bonghan system (BHS). The
small size (< 3 mm) and optical transparency of the system
were probably the main reasons for its delayed discovery.
Kim and his research team [2e5] published four additional
reports by the end of 1965, and the content of the reports
strongly implied the system’s importance in the mammalian
physiology. Kim’s claim of the system being the acupuncture
meridian particularly surprised the scientific community.
Unfortunately, Kim’s research activities suddenly stopped in
1965 [6] and had undergone a dormant period until Kwang-
Sup Soh reopened the research on the system in 2000. By
2002, new scientific results on the system started to appear
in various journals, and in 2010, the system was renamed as
the primo vascular system (PVS) [6,7].
The BHS/PVS consists of the ducts (vessels), corpuscles
(nodes), various fluid-containing cells, and biochemicals
that flow throughout the system. The following are the
terms used during the Kim’s time and those after the
Bonghan system became the PVS, placed side by side:Bonghan system Primo vascular system (PVS)
Bonghan duct Primo vessel (PV)
Bonghan ductule Subprimo vessel (Sub-PV)
Bonghan corpuscle Primo node (PN)
Sanal (or Bonghan sanal) Primo microcell (P-microcell)
Bonghan liquor Primo fluid (P-fluid)Kim also named the subunits of sanal as the sanalosome,
sanaloplasm, and sanal membrane, which were not
renamed by PVS scientists. A new term “primogenesis” was
created in 2012, by the University of Louisville team
(Louisville, KY, USA), to define the phenomenon of gener-
ating or forming the PVS, while describing the new PVS
formation on/in the cancer xenografts.
Kim [2,3] classified the system into several subtypes by
their locations. As his research progressed and more details
on the system were uncovered, his classification became
also updated. The subtypes are as follows. (1) Internal (or
intravascular): floating inside blood and lymphatic vessels
(LVs). (2) External (or extravascular): outside the blood
vessels and nerves, or independently. (3) Intraexternal:
freely on the surface of internal organs in thoracic/
abdominal cavities. (4) Intraorganic: inside organ walls. (5)
Neural: in/on the central and peripheral nervous systems.
(6) Superficial: in the corium or subcutaneous tissue. This
subtype was to be surrounded by dense blood vessels and
was close to nerves. Kim reported the corpuscles of this
subtype to be acupoints and the ducts to be the acupunc-
ture meridian.
Currently, all subtypes except the external subtype are
positively identified [7,8]. After observing the path of a
radioactive tracer injected into predetermined Bonghan
corpuscles, Kim [2,3] concluded that the subtypes closely
communicated with each other and that the system did not
appear to be controlled by a single central unit, but by
multicompartmentalized units.As Kim’s publications were reports (not journal publi-
cations requiring peer review processes), his findings were
to be verified before they were taken as scientific facts.
Until now, only some of Kim’s findings have been re-
examined and verified, and many are still to be investi-
gated. Since 2000, PVS scientists have also reported new,
important findings about the system, and some of the
notable scientific findings on the BHS/PVS are as follows.
(1) Kim claimed that the superficial BHS was the acupunc-
ture meridian [1e5], and, recently, the Ryu team [8] in
Korea colocalized the acupoints and superficial Bonghan
corpuscles/PNs in the abdomen of animal models, vali-
dating Kim’s claim. (2) After 2000, PVS scientists confirmed
it to be independent of the blood or lymphatic system by
the differences in microanatomical structures and bio-
markers [9]. (3) The BHS/PVS is an extensive network
throughout the entire mammalian body [3,7]. (4) The P-
microcells, which Kim named as sanals (live eggs, in
Korean), are now confirmed to be unique types of stem
cells, and positively confirmed to be performing nonmarrow
hematopoiesis and repairing damaged cells/tissues
[5,10e12]. (5) Bonghan liquor/P-fluid contains various bio-
chemicals and cells, particularly those associated with im-
mune responses [2,3,13]. (6) The PVS appears to have a role
in the dynamics of cancer metastasis [9,14], which is a new
finding after 2000.
Although only limited facts on the BHS/PVS have been
revealed so far, the nature of these listed above clearly
demonstrates the importance of the system in the
mammalian physiology. Despite the urgency for a thorough
investigation on this important system, there are still
serious impeding issues in performing PVS research. The
most serious one is lacking scientific tools to properly
handle its extremely small size (PV, 20e50 mm;
PN < 1500 mm) and optical transparency [1e5], which cause
difficulties in identifying and harvesting the system. Kim
presented his study results logically with reasonable de-
tails, but did not describe the methods for identifying and
harvesting the PVS in animal models at a level that future
scientists can repeat his studies. New techniques for iden-
tifying/harvesting the PVS have been reported since 2000,
but they are still not satisfactory for most of the scientists,
particularly those who are new to the system, to be able to
reliably access the PVS sample to perform in-depth
investigation.
In this article, in an effort to support the scientific
advancement in the system, the authors have analyzed
important issues to overcome and attempted to suggest
potential techniques to resolve these issues. We hope that
other PVS scientists also share their ideas with the PVS
community.
It should be noted that, the term “PVS scientists” in this
article is used to represent the scientists who have been
involved in PVS research after 2000. For the scientific terms
associated with the system, PVS (not BHS) terms are mainly
used to avoid unnecessary confusion.2. Identifying PVS with nanoparticles
For properly performing any scientific research, the target
sample needs to be identified first. Frequently, utilizing
Technical Challenges in PVS Research and Solutions 299biomarkers specific for the target sample is helpful, but
identifying/developing PVS biomarkers has not been real-
ized yet because of the difficulties in obtaining sufficient
amount of PVS samples. Identifying the PVS in the entire
body, with the help of appropriate contrast agents, using
medical imaging modalities could be a way of obtaining
sufficient samples. However, the usual spatial resolution
obtainable with these tools would be 100 mm at best [15],
which is much bigger than the average PV diameter.
Although some advanced modalities such as specially
designed magnetic resonance imaging [16e18] and electron
or X-ray microscopy [19e21] provide exceptionally good
resolution, they are not readily available to most scientists
and not practical for real-time sample harvesting from
animal models. Therefore, the main technique for identi-
fying the PVS has been optical (stereo) microscopy,
particularly for studies involving surgeries in live animals,
which is the current situation for most PVS studies.
Identification of the PVS has been performed by taking
advantage of its natural anatomical structure, and the PV is
known to have at least three unique characteristics (Fig. 1),
according to Kim [2,3] and later PVS scientists [19e22]: (1)
multiple sub-PVs in a single PV (Figs. 1A and 1B), and the
inter-sub-PV space filled with fibrous, amorphous sub-
stances [3]; (2) rod-shaped nuclei of sub-PV endothelial
cells (Fig. 1A) [3]; and (3) pores in the PV external wall
(Fig. 1B). The second property is helpful for confirming
whether the harvested sample is a PV or not. The first and,
particularly, the third properties have been effectively
utilized for placing appropriate optical contrast agents into
the PV. It is still not confirmed whether these pores exist in
the outer membrane of all six PVS subtypes, but this
property has been used for identifying the PVS inside the LV
and the intraexternal PVS [22e24]. Electron microscopy
and X-ray microscopy [19e21] have determined the pore
size of the outer wall of the rabbit intraexternal PV to beFigure 1 Properties unique for the PV. (A) PV illustrated in Kim
endothelial cell; 3-rod shaped nucleus of endothelial cell; 4-PV e
diagram of a PV cross section: pores in the PV outermost wall; mult
PV Z primo vessel; sub-PV Z subprimo vessel.1e5 mm, and the size of the PV or the pore does not seem to
vary significantly among the species studied. According to
Kim [3], the interstitial space of sub-PVs (ductules) has a
fibrous structure and is filled with amorphous substances.
Therefore, if particles of an appropriate size (i.e., smaller
than the pore in the PV wall, but similar to or slightly larger
than the spacing in the fibrous structure) are applied to the
PV from outside, they are expected to get into the PV via
the pores and be retained in the interstitial space. If these
particles possess an appropriate optical property, then they
would generate optical contrast for the PV.
Fig. 2 schematically describes the mechanism of iden-
tifying the PVS inside an LV (intra-LV PVS) using nano-sized
contrast agents. The LV is a good site for identifying the PVS
because it has a translucent vessel wall and its fluid is clear,
and, therefore, the optically contrasted, intra-LV PVS can
be seen through the LV wall. In this procedure, the contrast
agent at an appropriate size is first injected into the lymph
node connected to the target LV until the LV is filled with
the particles (Fig. 2A), and in time, the particles would
enter the PV via the pores. The natural flow of lymphatic
fluid clears particles from the LV (outside the PV), while the
particles that have already entered the PV remain in the
interstitial space, providing optical contrast to the PV
(Fig. 2B).
One such method exploits the unstable nature of Alcian
blue at a pH of > 5.6 [25]. Alcian blue is dark green in color,
its molecular size is 2e3 nm, and it is frequently used in
staining acidic mono- or polysaccharides of biological
samples in histological studies [26]. This dye itself, how-
ever, does not appear to stain the PVS preferentially to the
LV. For the purpose of PVS identification, Alcian blue
powder is first dissolved in PBS (pH 7.4); the solution is
boiled (possibly to maximize its solubility in PBS) and
filtered to remove large particles. The Alcian blue solution
is then injected into the lymph node of the animal until the’s third report (slightly modified from [3]; 1-sub-PV; 2- sub-PV
xternal layer; 5-nucleus of PV endothelial cell. (B) Schematic
iple sub-PVs in a PV; and fibrous nature of PV interstitial space.
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Figure 2 Schematic diagrams illustrating the identification of the PVS inside an LV using nano-sized contrast agent. (A) PVS-
containing LV is filled with nanoparticles, by injecting them into the lymph node. The particles get into the PV via the pores of
the PV external vessel wall. (B) The LV is cleared by its natural fluid flow, while the PVS retains the particles trapped in it,
generating optical contrast. LVZ lymphatic vessel; PVZ primo vessel; PVS Z primo vascular system; sub-PV Z subprimo vessel.
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small particles due to its instability in the PBS and
lymphatic fluid at pH 7.4. The actual size of the formed
Alcian blue particles is not known, but they go through the
pore in the PV outer membrane and remain in the inter-
stitial space, generating contrast for the PVS. The dye
preparation and injection steps should to be carried out
within a short period of time (not clearly defined yet)
before larger particle formation and/or precipitation
starts.
A more controlled and user-friendly method is using
nano-sized particles of an appropriate size range and op-
tical contrast against hemoglobin. The University of Louis-
ville team has developed a technique utilizing hollow gold
nanoparticles (HGNs) with a color range from green to blue
[27]. HGNs were selected because gold is biocompatible
and the size and color of HGNs can be controlled well. In a
preliminary study using the rat model, particles in the size
range of 50e125 nm worked well, with a success rate of 95%
[28]. This method has advantages over the Alcian blue
method, because the HGNs have a relatively homogeneous
size distribution, preparation steps are simpler, and the PVS
in the LV becomes visible within 20 minutes after the
particle injection.
The nanoparticle optical contrast agent used for the
purpose of intra-LV PVS identification requires certain
properties when used in live animals: (1) it must be
nontoxic, biocompatible, and chemically inert because it is
to be injected into LVs; (2) the particle surface should be
relatively hydrophilic and should not easily aggregate; and
(3) it needs to provide a strong optical contrast against the
tissue background (i.e., hemoglobin color). According toour experiments, dark green, greenish blue, or dark blue
seems to fit well for the purpose.
Up to now, five out of the six PVS subtypes (except the
external subtype) have been positively confirmed. The su-
perficial PVS may also need to be given special attention
because this subtype is said to be directly related to the
acupuncture therapy, and a thorough understanding of this
subtype may help in optimizing the therapy. Kim [2] illus-
trated how the radioactive tracer injected to a Bonghan
corpuscle (PN) in the skin moved to other corpuscles via the
meridian. Besides the study by Kim, there have been
several studies on tracing meridian paths using radioactive
tracers or dyes, by injecting them into a particular acupoint
(not Bonghan corpuscles or PNs) [29e33]. Since dealing
with radioactive tracers is not ideal, the method developed
by Lim et al [8] for the colocalization of PNs and acupoints
in the abdominal hypodermis region of rats using the three-
solution Hemacolor system may be a better approach.
The subtype that is most difficult to identify seems to be
the external PVS subtype, judging from the lack of scientific
articles on this subtype. The external PVS was reported to
be covered with connective tissue, according to Kim [3],
and, therefore, accessibility to the pores on its external
wall is still not known.3. Harvesting PVS via microelectromechanical
system
As described in the Introduction, most PVS scientists have
already recognized the potential health benefits that may
be achieved by appropriately manipulating the nature of
Figure 3 A PVS identified inside an LV, using HGNs. (A) The
PVS contrasted by the HGNs can be seen inside the LV. (B) After
the lower end of the PVS bearing LV is cut, the PVS is curled up
in the LV. HGN Z hollow gold nanosphere; LV Z lymphatic
vessel; PN Z primo node; PV Z primo vessel; PVS Z primo
vascular system.
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microcells or detecting cancer via the abnormally formed
PVS, etc. However, much of the fundamental information
about the PVS (e.g., micro- and submicroanatomical
structures, biological compositions, biomarkers, physiolog-
ical functions, the entire PVS map in the body, and
communication between the PVS and other organs) still
remains to be studied before any translational work can be
done. Besides, we still need to verify all of Kim’s findings,
which were published 50 years ago.
To acquire these basic scientific information, PVS sam-
ples need to be available in a reliable manner, but acquiring
a sufficient amount of PVS samples has been difficult
because of its small size as well as its identification-related
issues already described. The sites that may potentially
provide a relatively large amount of PVS samples are the
blood and LVs because the PVS runs inside them and they
are long. Out of the two, LVs are better candidates, as
mentioned earlier.
Identification of the intra-LV PVS can be performed more
easily in live animals because the floating motion of the PVS
in the lymphatic fluid helps identify it better. Once the LV
loses its fluid and becomes flattened, the PVS easily sticks
to the LV inner wall. Live animals, however, breathe and
the target LV also moves with the breathing motion, which
makes the harvesting tasks more challenging. Therefore,
keeping the target LV still during the breathing motion may
be helpful (e.g., fixing the LV on a solid surface). Next,
retrieving the PVS from the LV requires extremely delicate
microsurgical techniques with good microsized tools. A few
medical tools, such as micro-extra-fine surgical knives and
grippers (e.g., Excelta, Buellton, CA, USA; nanoScience
Instruments, Phoenix, AZ, USA), are currently available for
this type of study, although some of them can be expensive
and may still need to be tailored for PVS research. The tip
of the atomic force microscope may potentially serve as a
microknife. A suggested method for the intra-LV PVS, once
it is identified, is as follows: make small incisions at two
positions on the LV, depending upon the desired amount of
PVS samples; then insert the tips of two sets of micro-
grippers (e.g., nanoScience Instruments) into the two
respective incision sites of the LV, to hold the two ends of
the PVS; cut the LV along its length between the two inci-
sion sites; and cut the two ends of the PVS (outer sides of
the grippers) and retrieve the freed PVS by lifting the
grippers.
One might suggest to first harvest the PVS-containing LV
and then retrieve the PVS from it, in order to simplify the
process. However, when the LV is cut without holding the
two ends of the PVS, the PVS tends to curl up inside the LV
because of its elastic nature. Fig. 3 shows the PVS optically
contrasted by HGNs, before (Fig. 3A) and after (Fig. 3B) the
LV-containing PVS was cut at its lower part, and the PVS is
shown to curl up after the LV was cut. In addition, if PVS
retrieval is not performed immediately after the LV is cut,
then the PVS may stick to the inner wall of the LV, which
makes it difficult to harvest the PVS.
Since the entire procedure involved in the PVS harvest
requires precise operation due to the small target sample
size, if the procedure is performed by a micromanipulator
based on the microelectromechanical system (MEMS)
technology, human errors may be minimized. It is alsohighly desirable to have microliter-sized P-fluid collectors
and/or microinjectors, utilizing MEMS technology, for the
P-fluid analysis and applying biochemicals into the PVS.4. P-microcell retrieval by cell sorting
techniques
Kim [4] reported that there are unique, self-regenerating
cells (P-microcells/sanals) inside the PVS, particularly in
the PNs [5], and these cells are now positively confirmed to
be stem cells [11,12]. A thorough understanding of P-
microcells and their roles would, therefore, be very
important for the stem cell science and regenerative
medicine, and retrieving these cells from PNs in a reliable
manner is the first step toward it. This may be done, first,
by mechanically or enzymatically disintegrating the outer
layer of PNs to obtain all cells inside them, and then
separating the P-microcells from other cells. Since the
constituents or properties of the PN membrane are still not
clearly known, development of an optimized process for
removing the membranes may have to wait until they are
well characterized.
After the membranes are removed, P-microcells need to
be separated. Over the past decade, cell-sorting tech-
niques have been advanced significantly because detecting
circulating cancer cells has been emphasized as an impor-
tant research topic for early cancer diagnosis. The P-
microcell is characterized by its small size, 1e3 mm
302 K.A. Kang et al.[10e12], while most cells are in the range of 10 mm.
Therefore, P-microcells may be separated from the cell
population in PNs by flow cytometry, either using the dif-
ference in cell size [34] or by fluorescence [35] after la-
beling the cells with fluorophores via antibodies against
stem cell biomarkers that P-microcells express [10,36]. For
PVS studies, it may also be advantageous to use micro-sized
cell-sorting systems [37,38] instead of using a regular flow
cytometer, since PNs are very small, and the cell volume
and number in a PN are very small.5. Optical microscopy for PVS characterization
Optical microscopy was one of the most important methods
used in the discovery of the BHS in the 1960s, and redis-
covery of the PVS in the 2000s [39], although it was used
mainly for PVS identification instead of characterization. If
it is to be used for PVS characterization, the micro- and/or
submicrostructural components and translucent optical
property of the PVS, however, present serious challenges.
In the visible light transmission and reflection microscopy,
even for advanced confocal devices, the lateral image
resolution would not exceed 180 nm [40], requiring sub-
stantially enhanced resolution [41] for detailed structural
characterization of the PVS.
Optical resolution up to the submicron level may, how-
ever, be achieved via the annular illumination to increase
the intensity of diffraction fringes, and via the coherent
illumination of small (compared to wavelength) objects toFigure 4 Optical images of a nonfixed, intraexternal PVS from a ra
A magnified image of the part connecting the PN and PV in Fig. 4A.
rectangle in Fig. 4A. (D) A further magnified view of the PV shown i
arrows. The scale bars in A, B, C, and D are 500 mm, 200 mm, 100 mm,
PVS Z primo vascular system.allow the image edge to become sharper, thus increasing
the resolution [42e46].
Minimizing the light spot size on the sample and reducing
the stray light can also improve spatial resolution and
contrast: reducing the spot dimension raises the irradiance
of the sample and increases the contrast by increasing the
interaction with small particles in the sample. The photon
density of the system modified by the Auburn University
team (Auburn, AL, USA) became approximately 150 times
higher than that of the conventional Nikon darkfield
condenser (Eclipse E400, Oil 1.43-1.20, Japan). This
increased illumination intensity raises the optical differ-
ence between tiny light-scattering particles and their
background. By doing so, all particles larger than 90 nm,
including small DNA granules and P-microcells, can be
resolved [42]. A high-output numerical aperture of an illu-
mination system allows utilizing high numerical apertures
of the microscope objective and produces highly luminous
super-resolution images.
Figs. 4 and 5 are images with significantly enhanced
resolution and contrast, taken by the Auburn University
team with proper adjustments described above. Fig. 4
shows an image of an intraexternal PN connected to a PV
[3], which was harvested from the surface of the rat in-
testine. PNs are usually linked to the PVs at their both ends,
and in some cases, several PVs are connected to a single
PN. This particular PN was, however, connected to the PV
at its one end only (Figs. 4A and 4B). Figs. 4B and 4D are
enlarged images of the rectangular sections in Figs. 4A and
4C, respectively. The PVS sample was treated with acridinet, stained with acridine orange. (A) Overall view of the PVS. (B)
(C) A magnified image of the branched PV, shown in the dotted
n the dotted rectangle in Fig. 4C. Its cell nuclei are shown with
and 50 mm, respectively. PNZ primo node; PVZ primo vessel;
Figure 5 A transverse sectional view of a small PN. (A) In the brightfield mode, basophilic granules are labeled with black stars.
(B) The same section photographed in the darkfield mode. Vacuoles are indicated by white arrows, intravascular space by a white
arrow head, cluster of granules by a black arrow, a granule in the small lumen by a black arrow head, the largest lumen by a white
star, and the interrupted portion of lumen connected to a vacuole by a dotted white arrow. CZ capsule; LZ lumens; PNZ primo
node.
Technical Challenges in PVS Research and Solutions 303orange, which is used as a nucleic-acid-selective fluores-
cent cationic dye. The staining reveals cells fluorescing
with green and red light: the light at a wavelength of
502 nm excites the acridine orange/DNA complex that
emits at 525 nm (green). When it interacts with RNA,
excitation shifts to 460 nm and emission to 650 nm (red)
[47]. In these images, the details of this PVS may be very
clearly seen: the PN has an oval shape with dimensions of
0.85  1.1 mm2 and the PV length is 1.25 mm. The diameter
of the middle part of the vessel isw140 mm. The apical end
of the vessel is branched into two smaller vessels. The
branched vessels are connected to other nodes (not shown
here). The green and red colors may be interpreted as DNA
and RNA of cell nuclei, but acridine orange also accumu-
lates and emits red light in mast secretory granules and
other cellular acidic compartments [48,49]. In Fig. 4D, the
red color is emitted from the cell cytoplasm rather than
from the cell nuclei. The nuclei of these cells (shown by
arrows) are green. These particular cells represent w5% of
the entire cell population. Microscopic observation of the
mast cells under the acupuncture meridian lines of humans
and rats revealed that the mast cells were more concen-
trated under the meridian lines in comparison with their
control areas. Therefore, the red-stained cells in the figure
may be mast cells [50e53]. According to this result, the
mast cells represent w5% of acridine orange-stained cells
in the PVS, which is close to 4%, as quantified by Lim et al
[53], but less than 20%, as reported by Kwon et al [13]. The
difference may be due to variations in techniques and
experimental conditions.
Fig. 5 illustrates the transversal section of a PN in the
bright and dark field modes (Figs. 5A and 5B, respectively).
The walls of sub-PVs are smooth, single layered, and un-
interrupted, except for the wall of the lumen labeled by the
white star. There is a small opening in the wall that leads to a
vacuole (dottedwhite arrow). Some sub-PVs run very close to
each other, with a small intravascular space between them
(white arrow head). The section also shows randomly
scattered single cells and granules, and some granules are in
clusters (black arrow). These features shown in the optical
image of the PN cross section agree with those described by
electron and light microscopy in general [22,54].As illustrated here, optical microscopy with proper
adjustment can be utilized effectively for PVS character-
ization in a micron/submicron level.6. Studying cancer primogenesis via
fluorescent protein
Most PVS studies performed up to now have focused on the
identification and basic characterization of the system
probably because the system is still new. However, there
have been interesting preliminary study results on the be-
haviors of the PVS in/adjacent to cancerous tumors (cancer
PVS), at least for six different cancer xenografts. Although
this topic is not associated with basic characterizations of
the normal PVS, we included it in the article because
cancer affects many people, and a thorough understanding
of the cancer PVS may lead to better management of the
disease. The cancer xenografts studied up to now are: lung
(NCI-H460) and ovarian (SK-OV-3) cancer [9,14], cutaneous
melanoma (B16 F10) [55], breast cancer (MDA-MB231),
gastric cancer (MKN12) [56], human leukemia (U937) [57],
and also human breast cancer mimicking cell line 4T1 [58].
The PVS in/on normal tissues or organs is usually neither
very densely populated nor easily observed. The cancer
PVS, however, has been shown to form at a higher density
in/around the tumor. In addition, cancer PVS has been
shown to participate in cancer cell transport from the pri-
mary to the secondary tumors [9,14].
To learn how the cancer PVS proliferates, Heo et al [55]
used a combination of green fluorescent protein (GFP)-
expressing host animals and nonfluorescing human skin
cancer cell line, and the result showed that GFP PVS was
formed inside the tumor. The Soh team [56] used a GFP-
expressing cancer cell line in nonfluorescing animal
models and observed the GFP-producing cancer cells
transporting via the PVS. Results of another study, by Islam
et al [57], using a lymphoma xenograft showed that the
cells in the cancer PN were human-origin, i.e., from the
cancer, not from the host. These cells exhibited stem-cell-
specific transcription factor KLF4 at a significantly upregu-
lated level. It is still not clear whether the cancer PVS is
304 K.A. Kang et al.formed from the host, tumor, or both, and whether these
cells are in fact cancer stem cells, all of which are very
important information for the cancer metastasis and the
sources of cancer stem cells.
The study using a GFP-expressing host with no-
fluorescence-expressing cancer cells [55] may not have
complete information on the hostexenograft communica-
tion because GFP can provide information from the host
only. By the same reason, the study using a GFP-expressing
cancer cell line in nonfluorescing animal models was not
able to tell us the roles of the host animal in cancer pri-
mogenesis. A more complete method suggested here is
combining the animal model expressing one fluorescing
protein (e.g., GFP) and the cancer cells expressing another
fluorescing protein (e.g., red fluorescent protein). This
method can help in finding the origin (i.e., the host or the
cancer) of the PVS and its subunits by individual fluores-
cence. A study of the cancer PVS growth path and pattern,
and cancer P-microcell production by the color of fluores-
cence should tell us the role of the PVS in cancer primo-
genesis and the source of the cancer stem cells.7. Nontechnical issues
In addition to the numerous technical issues that need to be
overcome, there are also nontechnical issues that affect the
advancement in the PVS science. The PVS is still very new to
most scientists, and therefore, the concept that there is
another vascular system in the mammalian body has still not
been accepted easily. Publishing PVS research results in
reputableWestern journals and/or receiving research grants
for PVS study has also been extremely difficult. In addition,
the PVS research community, which is still relatively small,
suffers from poor information exchange, which may lead
research teams to overlap efforts and funds, slowing the
advancement in science. With the current situation, the PVS
science is desired to advance in a highly organized, multi-
disciplinary manner, because the scientific subjects to
tackle for the PVS is so broad and extensive. If the PVS
community forms a consortium, each PVS research team is in
charge of a particular topic of the PVS science, and then
shares the study results openly within the community, the
advances in the PVS sciencewould be faster. In addition, PVS
scientists should attempt to vigorously disseminate the
research results via high-quality journal publications,
research grant proposals, conference presentations, and
lectures, and educate junior PVS scientists.
As the PVS science is still new, individuals who recently
became involved in the PVS study may knowingly mislead
other scientists for their own sake. For example, some
scientists have renamed the system (we already have 2 sets
of names for the system) and some have avoided revealing
important details of the experimental methods in the
publications. The potential chaos generated by this type of
actions may disorient the scientific community, especially
those who desire to participate in PVS research. It could
also impede the recognition of validity of the results and
terminologies that have already been accepted by the in-
ternational community. The efforts of Drs Bonghan Kim and
Kwang-Sup Soh for establishing the bases of the BHS/PVS
science should be respected and honored.8. Conclusion
For the past decade, there have been numerous scientific
reports and articles on the BHS/PVS. Based on the already
reported findings, the PVS has been proven to be an inde-
pendent vascular system and it may have important roles in
mammalian physiology, even though its existence is still not
known to many scientists.
In this article, we have discussed difficulties to be
overcome in the current PVS research approach with sug-
gested new methods. It is our hope that this article will be
helpful for PVS scientists in general, and that other scien-
tists would join us to share their ideas to resolve other
problems so that we can together elucidate the roles and
functions of the PVS in mammals. Ultimately, we hope that
accumulated knowledge on the PVS, via effective commu-
nication among PVS scientists, is utilized for the preven-
tion, diagnosis, and treatment of diseases.
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